Research Article
KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?
Table 4
Contingency table for determination of BRAF mutation status using immunostaining.
| |||||||||||||||||||||||||||||||||||
Sensitivity = 20/20 = 100%. Specificity = 10/10 = 100%. |